HighTower Advisors’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $205K | Sell |
30,179
-1,176
| -4% | -$8.69K | ﹤0.01% | 3464 |
|
|
2025
Q4 | $365K | Buy |
31,355
+355
| +1% | +$3.92K | ﹤0.01% | 2877 |
|
|
2025
Q3 | $361K | Buy |
31,000
+3,000
| +11% | +$36.3K | ﹤0.01% | 2885 |
|
|
2025
Q2 | $345K | Sell |
28,000
-1,138
| -4% | -$12.6K | ﹤0.01% | 2810 |
|
|
2025
Q1 | $179K | Hold |
29,138
| – | – | ﹤0.01% | 3225 |
|
|
2024
Q4 | $236K | Buy |
29,138
+9,566
| +49% | +$95.5K | ﹤0.01% | 3072 |
|
|
2024
Q3 | $158K | Buy |
19,572
+434
| +2% | +$2.35K | ﹤0.01% | 3210 |
|
|
2024
Q2 | $83K | Hold |
19,138
| – | – | ﹤0.01% | 3238 |
|
|
2024
Q1 | $81K | Hold |
19,138
| – | – | ﹤0.01% | 3191 |
|
|
2023
Q4 | $73K | Hold |
19,138
| – | – | ﹤0.01% | 3252 |
|
|
2023
Q3 | $71K | Sell |
19,138
-17,250
| -47% | -$68.6K | ﹤0.01% | 3176 |
|
|
2023
Q2 | $145K | Buy |
36,388
+17,250
| +90% | +$85.3K | ﹤0.01% | 2977 |
|
|
2023
Q1 | $79K | Hold |
19,138
| – | – | ﹤0.01% | 2984 |
|
|
2022
Q4 | $80K | Hold |
19,138
| – | – | ﹤0.01% | 2966 |
|
|
2022
Q3 | $54K | Hold |
19,138
| – | – | ﹤0.01% | 2869 |
|
|
2022
Q2 | $77K | Buy |
19,138
+5,000
| +35% | +$18.6K | ﹤0.01% | 2841 |
|
|
2022
Q1 | $78K | Sell |
14,138
-1,500
| -10% | -$6.87K | ﹤0.01% | 3026 |
|
|
2021
Q4 | $72K | Buy |
15,638
+1,500
| +11% | +$7.45K | ﹤0.01% | 2984 |
|
|
2021
Q3 | $66K | Hold |
14,138
| – | – | ﹤0.01% | 2908 |
|
|
2021
Q2 | $97K | Hold |
14,138
| – | – | ﹤0.01% | 2818 |
|
|
2021
Q1 | $141K | Sell |
14,138
-2,200
| -13% | -$23.2K | ﹤0.01% | 2691 |
|
|
2020
Q4 | $121K | Buy |
+16,338
| New | +$111K | ﹤0.01% | 2315 |
|
|
2019
Q1 | – | Sell |
-7,438
| Closed | -$48K | – | 2316 |
|
|
2018
Q4 | $48K | Sell |
7,438
-2,200
| -23% | -$14.7K | ﹤0.01% | 2032 |
|
|
2018
Q3 | $47K | Buy |
9,638
+200
| +2% | +$492 | ﹤0.01% | 2128 |
|
|
2018
Q2 | $11K | Hold |
9,438
| – | – | ﹤0.01% | 2136 |
|
|
2018
Q1 | $9K | Buy |
9,438
+2,000
| +27% | +$3.99K | ﹤0.01% | 2089 |
|
|
2017
Q4 | $19K | Sell |
7,438
-6,000
| -45% | -$17.2K | ﹤0.01% | 2161 |
|
|
2017
Q3 | $35K | Hold |
13,438
| – | – | ﹤0.01% | 2102 |
|
|
2017
Q2 | $29K | Buy |
13,438
+4,000
| +42% | +$13.7K | ﹤0.01% | 2051 |
|
|
2017
Q1 | $77K | Buy |
9,438
+3,000
| +47% | +$28.6K | ﹤0.01% | 1893 |
|
|
2016
Q4 | $49K | Hold |
6,438
| – | – | ﹤0.01% | 1815 |
|
|
2016
Q3 | $81K | Buy |
6,438
+1,000
| +18% | +$9.35K | ﹤0.01% | 1755 |
|
|
2016
Q2 | $54K | Sell |
5,438
-563
| -9% | -$8.57K | ﹤0.01% | 1640 |
|
|
2016
Q1 | $80K | Buy |
6,001
+2,001
| +50% | +$19.4K | ﹤0.01% | 1930 |
|
|
2015
Q4 | $41K | Buy |
4,000
+2,000
| +100% | +$23K | ﹤0.01% | 1902 |
|
|
2015
Q3 | $20K | Buy |
+2,000
| New | +$30.8K | ﹤0.01% | 1828 |
|
Other funds holding CRMD
DTC
VCM
RA
OAM
VPM
HighTower Advisors's CRMD Position: Q1 2026 in Review
HighTower Advisors reduced its CorMedix (CRMD) stake by 3.8% in Q1 2026, selling an estimated $8.69K and leaving 30,179 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.
HighTower Advisors first reported a position in CRMD in Q3 2015 and has held it in 36 quarters since. The position peaked at $365K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.
- HighTower Advisors held 30,179 shares of CorMedix worth $205K as of Q1 2026.
- HighTower Advisors sold 1,176 CorMedix shares in Q1 2026, an estimated $8.69K.
- CorMedix made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3464 holding.
- HighTower Advisors first reported a position in CorMedix in Q3 2015 and has held it in 36 quarters since.
- HighTower Advisors's CorMedix position peaked at $365K in Q4 2025.
- 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.